Classify doses by intensity and estimated LDL effect. Check actual reduction against expected therapeutic ranges. Download reports and compare therapy scenarios with clear visuals.
Use this tool to classify a statin regimen, estimate the expected LDL-C lowering band, compare actual response against baseline values, and export a clean summary. It is an educational calculator and not a prescribing order sheet.
| Case | Statin | Dose | Baseline LDL-C | Current LDL-C | Reduction | Calculated Intensity |
|---|---|---|---|---|---|---|
| A | Atorvastatin | 40 mg | 190 | 92 | 51.6% | High |
| B | Rosuvastatin | 10 mg | 158 | 94 | 40.5% | Moderate |
| C | Pravastatin | 20 mg | 146 | 112 | 23.3% | Low |
| D | Pitavastatin | 2 mg | 171 | 111 | 35.1% | Moderate |
1. Intensity classification: The selected statin and dose map to a standard intensity band.
2. Actual LDL-C reduction %: ((Baseline LDL-C − Current LDL-C) ÷ Baseline LDL-C) × 100
3. Expected on-treatment LDL-C range: Baseline LDL-C × (1 − expected reduction band)
4. Gap to target: Current LDL-C − Target LDL-C
5. Needed reduction from current: ((Current LDL-C − Target LDL-C) ÷ Current LDL-C) × 100
These formulas summarize expected response bands and do not replace patient-specific clinical judgement, interaction screening, or laboratory review.
It describes the expected average LDL-C lowering from a regimen. High intensity usually lowers LDL-C by at least half, moderate by 30% to 49%, and low by less than 30%.
No. It classifies a selected regimen and compares measured lipid changes. Medication choice still depends on diagnosis, tolerance, interactions, pregnancy status, kidney function, and clinician review.
Baseline LDL-C allows the calculator to estimate expected on-treatment ranges and compute the actual percentage reduction after treatment values are entered.
The tool will show a negative response. That can happen because of data entry errors, poor adherence, timing issues, secondary causes, or inadequate regimen effect.
That dose carries major safety restrictions. Many tools leave it out of ordinary starting options and direct users to clinician review instead of routine selection.
Yes. The form includes optional baseline and current non-HDL-C fields so you can export a broader lipid summary alongside LDL-C response.
No. It is a teaching estimate based on intensity bands. Individual response varies with genetics, adherence, dose timing, absorption, interactions, and baseline risk.
This page only summarizes the entered timing. Actual follow-up intervals depend on clinical goals, dose changes, adherence questions, and local practice standards.
Important Note: All the Calculators listed in this site are for educational purpose only and we do not guarentee the accuracy of results. Please do consult with other sources as well.